This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.

https://www.barrons.com/articles/medtronic-upgrade-wells-fargo-stock-rising-8fc255d0

Medtronic Stock Has Room to Rise as ‘Major Milestone’ Is Reached: Wells Fargo

By
Brian Swint
  • Order Reprints
  • Print Article

The medical-technology company Medtronic grabbed an upgrade from Wells Fargo on Monday, helping push shares higher.

Analysts led by Larry Biegelsen raised their target for the stock price to $100 from $77 previously, changing their rating to Overweight from Equal Weight. They said the general medtech market is improving and that Medtronic’s (ticker: MDT) own pipeline of products is maturing. U.S. approval of the company’s 708G insulin delivery system is a “major milestone,” Wells Fargo said in a research report.

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.